-
Microdose @microdose
New Study: Evidence has shown that #ketamine has strong anti-depressant effects. The Nature study shows that ketamine treatments can rapidly increase #neuroplasticity. https://t.co/C3MRgg15od
visibility
986
New Study Shows Ketamine Improves Plasticity and Depression Results
microdose.buzz
May 24, 2023
A new study has shown that intravenous ketamine can improve depression symptoms in patients with treatment-resistant depression.
π³ Ayahuasca >

more_vert
No exemptions for Victoria Cannabis Buyers Club: Health Canada

more_vert
Cannabis Contract Approval Headaches

more_vert
The Largest Phase 3 Trial on Psilocybin for Depression Has Kicked Off | Psychedelic Spotlight
π΅ Psychedelics >

more_vert
No exemptions for Victoria Cannabis Buyers Club: Health Canada

more_vert
Cannabis Contract Approval Headaches

more_vert
The Largest Phase 3 Trial on Psilocybin for Depression Has Kicked Off | Psychedelic Spotlight
π Cannabis >

more_vert
No exemptions for Victoria Cannabis Buyers Club: Health Canada

more_vert
Cannabis Contract Approval Headaches

more_vert
The Largest Phase 3 Trial on Psilocybin for Depression Has Kicked Off | Psychedelic Spotlight
π Psilocybin >

more_vert
No exemptions for Victoria Cannabis Buyers Club: Health Canada

more_vert
Cannabis Contract Approval Headaches

more_vert
The Largest Phase 3 Trial on Psilocybin for Depression Has Kicked Off | Psychedelic Spotlight
π± Ketamine >

more_vert
No exemptions for Victoria Cannabis Buyers Club: Health Canada

more_vert
Cannabis Contract Approval Headaches

more_vert
The Largest Phase 3 Trial on Psilocybin for Depression Has Kicked Off | Psychedelic Spotlight
πΈ DMT >

more_vert
No exemptions for Victoria Cannabis Buyers Club: Health Canada

more_vert
Cannabis Contract Approval Headaches

more_vert
The Largest Phase 3 Trial on Psilocybin for Depression Has Kicked Off | Psychedelic Spotlight
π MDMA >

more_vert
No exemptions for Victoria Cannabis Buyers Club: Health Canada

more_vert
Cannabis Contract Approval Headaches

more_vert
The Largest Phase 3 Trial on Psilocybin for Depression Has Kicked Off | Psychedelic Spotlight
Also In Microdose

more_vert
CA Bill to Legalize Psychedelics Possession Expedited to Senate Floor

more_vert
Ketamine may be safe treatment for refractory migraineΒ

more_vert
US could soon approve MDMA therapy β opening an era of psychedelic medicine
Also In Technology

more_vert
Mushrooms' efficacy as treatment for mental disorders and addiction to be tested at UW Medicine

more_vert
CA Bill to Legalize Psychedelics Possession Expedited to Senate Floor

more_vert
The race to patent psychedelic drugs
A new study has shown that intravenous ketamine can improve depression symptoms in patients with treatment-resistant depression.